πŸ‡ΊπŸ‡Έ FDA
Patent

US 10258682

Attenuated chlamydia vaccine

granted A61KA61K2039/522A61K2039/53

Quick answer

US patent 10258682 (Attenuated chlamydia vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/522, A61K2039/53, A61K39/118